Debjit Paul

Debjit Paul is a seasoned professional with extensive experience in the pharmaceutical and healthcare sector. Currently serving as the Regional Therapy Access Manager for the Obesity Business Unit at Novo Nordisk, Debjit Paul is focused on shaping the obesity market in India and leading the launch of a significant anti-obesity drug. Previous roles include Regional Sales Manager at Dozee, where Debjit Paul successfully launched operations in East Zone, and similar positions at Medtronic, Baxter International Inc., Abbott, and Cipla, demonstrating a strong track record in sales management, market expansion, and team leadership across various therapeutic areas. Debjit Paul holds a Master of Science in Zoology/Animal Biology and has contributed to notable growth and development initiatives in each organization.